Drag

Unichem Laboratories Limited

Healthcare UNICHEMLAB

374.35INR
5.75 ( 1.56%)

Last update at 2026-01-30 15:45:22

Day Range

365.55379.35
LowHigh

52 Week Range

419.80 790.70
LowHigh

Fundamentals

  • Previous Close 368.60
  • Market Cap 29780.68M
  • Volume7,392
  • P/E Ratio 33.78
  • EBITDA 2507.00M
  • Revenue TTM 22258.30M
  • Revenue Per Share TTM 316.45
  • Gross Profit TTM 11960.60M
  • Diluted EPS TTM 12.50

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 1545.90M -616.66M -1763.63M 219.69M 514.79M
Net income 1375.20M -704.74M -2022.28M 330.62M 343.25M
Total Revenue 21109.70M 16574.16M 13254.48M 12557.45M 12048.67M
Gross Profit 12473.00M 3174.32M 7920.96M 8074.41M 7885.48M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 35694.00M 31693.44M 31930.49M 33187.74M 31257.14M
Intangible assets 187.00M 563.60M 0.00M 0.00M 0.00M
Other current assets 1808.20M 2268.34M 1859.53M 1709.85M 2605.87M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -655.20M -292.11M 745.56M 317.36M -1540.58M
Operating Cash -70.20M 140.00M -850.91M -2596.12M 330.99M
Free Cash Flow -1443.80M -58.53M -1294.06M -3866.14M -2547.16M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
UNICHEMLAB
Unichem Laboratories Limited 		5.75 1.56% 374.35 29780.68 33.78
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-6.60 -0.39% 1696.00 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-116.50 -1.90% 6025.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-40.70 -1.02% 3935.70 1362716.66 63.48
CIPLA
Cipla Limited 		-7.20 -0.54% 1326.10 1183505.97 21.74

Profile

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.

Unichem Laboratories Limited

47, Kandivli Industrial Estate, Mumbai, India, 400067

Key Executives

Name Title Year Born
Dr. Prakash Amrut Mody Chairman & MD 1953
Mr. Sandip Ghume Deputy Chief Financial Officer NA
Mr. Dilip Kunkolienkar Director of Technical & Whole-Time Director 1951
Mr. Pradeep Kumar Bhandari Head of Legal, Company Sec. & Compliance Officer 1958
Mr. Prasad Joshi VP of HR & ER 1958
Mr. Vinod Kumar Behl Head of Projects & Investments 1950
Mr. Bhagwat S. Dhingra Chief Exec. of Domestic Pharma 1963
Mr. Scott B. Delaney Pres of North America & CEO of North America 1969
Dr. P. B. Deshpande M.Sc. Ph.D. VP of Chemical of R&D 1955
Ms. Supriya Prakash Mody Associate VP of International Bus. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.